Effect of Vitamin C on Serum Cortisol after Etomidate Induction of Anesthesia
Journal of Cellular & Molecular Anesthesia,
Vol. 1 No. 1 (2016),
21 December 2015
Objectives: Etomidate is suitable for induction of anesthesia, especially in elderly patients and patients who have cardiovascular compromise. Vitamin C has been introduced as a treatment option to decrease Etomidate induced adrenal insufficiency but its actual effect is still controversial. Objective is to determine the effect of Vitamin C on reduction of serum cortisol after etomidate induction of anesthesia.
Methods: In a randomized clinical trial, 40 patients of ASA class I & II, aged between 25 to 70 years old, candidate for elective laparatomy were selected. One hour before induction of surgery, 1 gram of intravenous Vitamin C were administered to the patients in Vitamin C group. Two blood samples were obtained 5 minutes before induction and then another sample 4 hours after induction with etomidate after surgery. All samples were measured for serum free cortisol, ACTH, and C-reactive protein (CRP).
Results: There were no significant differences between duration of surgery, preoperative and post-operative blood pressure and heart rate in two groups (p>0.05). Serum cortisol was significantly declined in control group from 16.2±6.3 μg/dl in preoperative to 8.5±4.2 in postop (p=0.0005), but not in Vitamin C group from 17.5±5.6 in preop to 16.8±6.4 in postop (p=0.75). ACTH levels increased non-significantly from preop to postop period in both Vitamin C (pre: 52.1±15 vs. post: 56.4±18 pg/ml) (p=0.48) and in control group (pre:50.5±16 vs. post:56.2±20).
Conclusion: Etomidate could significantly decrease postoperative serum free cortisol and induce adrenocortical suppression and CRP increase. This effect could be reversed by using Vitamin C premedication to maintain serum cortisol at preoperative level.
- Vitamin C
How to Cite
Gooding JM, Weng JT, Smith RA, Berninger GT, Kirby RR. Cardiovascular and pulmonary responses following etomidate induction of anesthesia in patients with demonstrated cardiac disease. Anesth Analg. 1979;58(1):40-1.
Ebert TJ, Muzi M, Berens R, Goff D, Kampine JP. Sympathetic responses to induction of anesthesia in humans with propofol or etomidate. Anesthesiology. 1992;76(5):725-33.
Ledingham IM, Watt I. Influence of sedation on mortality in critically ill multiple trauma patients. Lancet. 1983;1(8336):1270.
Owen H, Spence AA. Etomidate. Br J Anaesth. 1984;56(6):555-7.
Allolio B, Dörr H, Stuttmann R, Knorr D, Engelhardt D, Winkelmann W. Effect of a single bolus of etomidate upon eight major corticosteroid hormones and plasma ACTH. Clin Endocrinol (Oxf). 1985;22(3):281-6.
Longnecker DE. Stress free: to be or not to be? Anesthesiology. 1984;61(6):643-4.
Sunshine JE, Deem S, Weiss NS, Yanez ND, Daniel S, Keech K, et al. Etomidate, adrenal function, and mortality in critically ill patients. Respir Care. 2013;58(4):639-46.
Lamberts SW, Bons EG, Bruining HA, de Jong FH. Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells. J Pharmacol Exp Ther. 1987;240(1):259-64.
Vinclair M, Broux C, Faure P, Brun J, Genty C, Jacquot C, et al. Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intensive Care Med. 2008;34(4):714-9.
Boidin MP. Steroid response to ACTH and to ascorbinic acid during infusion of etomidate for general surgery. Acta Anaesthesiol Belg. 1985;36(1):15-22.
Crozier TA, Beck D, Schlaeger M, Wuttke W, Kettler D. Endocrinological changes following etomidate, midazolam, or methohexital for minor surgery. Anesthesiology. 1987;66(5):628-35.
Wagner CE, Bick JS, Johnson D, Ahmad R, Han X, Ehrenfeld JM, et al. Etomidate use and postoperative outcomes among cardiac surgery patients. Anesthesiology. 2014;120(3):579-89.
de la Grandville B, Arroyo D, Walder B. Etomidate for critically ill patients. Con: do you really want to weaken the frail? Eur J Anaesthesiol. 2012;29(11):511-4.
van den Heuvel I, Wurmb TE, Böttiger BW, Bernhard M. Pros and cons of etomidate--more discussion than evidence? Curr Opin Anaesthesiol. 2013;26(4):404-8.
Chan CM, Mitchell AL, Shorr AF. Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis*. Crit Care Med. 2012;40(11):2945-53.
Boidin MP, Erdmann WE, Faithfull NS. The role of ascorbic acid in etomidate toxicity. Eur J Anaesthesiol. 1986;3(5):417-22.
Malerba G, Romano-Girard F, Cravoisy A, Dousset B, Nace L, Lévy B, et al. Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation. Intensive Care Med. 2005;31(3):388-92.
Pirbudak L, Balat O, Cekmen M, Ugur MG, Aygün S, Oner U. Effect of ascorbic acid on surgical stress response in gynecologic surgery. Int J Clin Pract. 2004;58(10):928-31.
Duthie DJ, Fraser R, Nimmo WS. Effect of induction of anaesthesia with etomidate on corticosteroid synthesis in man. Br J Anaesth. 1985;57(2):156-9.
Schraag S, Pawlik M, Mohl U, Böhm BO, Georgieff M. The role of ascorbic acid and xylitol in etomidate-induced adrenocortical suppression in humans. Eur J Anaesthesiol. 1996;13(4):346-51.
Dabbagh A, Sa'adat N, Heidari Z. Etomidate infusion in the critical care setting for suppressing the acute phase of Cushing's syndrome. Anesth Analg. 2009;108(1):238-9.
- Abstract Viewed: 884 times
- PDF Downloaded: 316 times